Schedule 13G ownership disclosure

Phathom Pharmaceuticals Inc

Common Stock · CUSIP: 71722W107

Event date: 2025-05-31

Filing-level shares
0
Percent of class
0%
  • Jennison Associates LLC

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-25-000074
Form type
SCHEDULE 13G/A
Filer
JENNISON ASSOCIATES LLC
CIK
CIK 53417
Filed
Jun 09, 2025
Reporting period
May 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub